Latest News about GILD
Recent news which mentions GILD
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
September 23, 2022
From Motley Fool
Here's How Much $100 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
September 20, 2022
Tickers
GILD
From Benzinga
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
September 20, 2022
From Benzinga
"The Era of the Gene-Edited Human Is Here"
September 19, 2022
From Motley Fool
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
From Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
From InvestorPlace
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease
September 16, 2022
From MarketWatch
WHO Recommends Gilead's COVID-19 Therapy For Severe Disease
September 16, 2022
Tickers
GILD
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
From Benzinga
Delayed Generic Entry Is Positive For This Large Pharma's HIV Franchise Sales, Analyst Says
September 15, 2022
Tickers
GILD
From Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
3 Unstoppable Dividend Stocks to Buy in September
September 13, 2022
From Motley Fool
Is First Trust Large Cap Core AlphaDEX ETF (FEX) a Strong ETF Right Now?
September 08, 2022
From Benzinga
Gilead's Trodelvy Shows Improved Overall Survival In Pretreated Breast Cancer Settings
September 08, 2022
Tickers
GILD
From Benzinga
Kite Pharma's CAR T-Cell Therapy Wins European Approval In Refractory Leukemia Setting
September 07, 2022
Tickers
GILD
From Benzinga
Gilead's Breast Cancer Drug Improves Progression-Free Survival in HR+/HER2- Metastatic Breast Cancer
September 06, 2022
Tickers
GILD
From Benzinga
3 Great Dividend Stocks to Buy in September
September 03, 2022
From Motley Fool
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
From Benzinga
Everest Medicines Descends To New Depths On String Of Bad News
September 01, 2022
From Benzinga
Want $1,100 in Passive Income? Invest $20,000 in These 2 Stocks
August 25, 2022
From Motley Fool
Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays
August 22, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 19, 2022
From Benzinga
From Benzinga
Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
August 18, 2022
From Benzinga
Can Faraday Future (FFIE) Stock Turn Its Cash Crunch Around?
August 16, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.